CHCHD5 and lung carcinoma: CHTM1 deficiency also enhanced p38 phosphorylation in metformin-treated lung cancer cells (Fig. 5e), and overexpression of CHTM1 inhibited p38 phosphorylation in metformin-treated cells (Fig. 5f).